4Filing Date: May 22, 2026

Guardant Health (GH) 4: Saia John G. sold 5,632 shares of Common Stock at $105.34 o… (May 22, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001737840-26-000012
Total Value$2.13M
Trades3
Insiders1

Transaction Details

Saia John G.
Chief Legal Officer·Direct
Sell · Dispose
Common Stock
Shares-5.63K
Price$105.34
Total Value$593.3K
Shares Owned After60.32K
Transaction DateMay 20, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.86. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Saia John G.
Chief Legal Officer·Direct
Sell · Dispose
Common Stock
Shares-7.19K
Price$106.71
Total Value$766.9K
Shares Owned After53.13K
Transaction DateMay 20, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Saia John G.
Chief Legal Officer·Direct
Sell · Dispose
Common Stock
Shares-7.18K
Price$107.23
Total Value$770.0K
Shares Owned After45.95K
Transaction DateMay 20, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.96. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Post-Transaction Holdings

Saia John G. · Chief Legal Officer
SecuritySharesChange
Common Stock60.32K-20.00K (-24.90%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-20 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Saia John G. CIK: 0001737840 Role: Officer (Chief Legal Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-20 | Code: S (Open market sale) Shares: -5,632 | Price: $105.34 Total Value: $593,293.47 Shares Owned After: 60,318 | Ownership: D (Direct) Footnotes: [F1] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.86. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #2] Security: Common Stock Date: 2026-05-20 | Code: S (Open market sale) Shares: -7,187 | Price: $106.71 Total Value: $766,939.14 Shares Owned After: 53,131 | Ownership: D (Direct) Footnotes: [F2] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #3] Security: Common Stock Date: 2026-05-20 | Code: S (Open market sale) Shares: -7,181 | Price: $107.23 Total Value: $769,996.37 Shares Owned After: 45,950 | Ownership: D (Direct) Footnotes: [F3] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.96. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. --- Footnotes (Complete Index) --- F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.86. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F3: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.96. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. --- Signature --- /s/ /s/ John G. Saia (2026-05-22)

keid analysis is for reference only and does not constitute investment advice.